Literature DB >> 21453219

Effects of race on albuminuria and risk of cardiovascular and kidney disease.

Vardaman M Buckalew1, Barry I Freedman.   

Abstract

The literature describing the relationship between urinary protein excretion and risk of cardiovascular disease and renal disease is rapidly proliferating. Several studies have demonstrated racial differences in the relationship between albuminuria and associated disorders. The purpose of this article is to summarize the effects of race on the relationship between albuminuria and renal and cardiovascular disease risk, propose explanatory hypotheses, and suggest directions for future investigation.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21453219      PMCID： PMC3171951          DOI： 10.1586/erc.10.185

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN： 1477-9072


  37 in total

1.  Childhood blood pressure predicts adult microalbuminuria in African Americans, but not in whites: the Bogalusa Heart Study.

Authors:  Sheikh Hoq; Wei Chen; Sathanur R Srinivasan; Gerald S Berenson
Journal:  Am J Hypertens       Date:  2002-12       Impact factor: 2.689

2.  Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.

Authors:  Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick de Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick E Grobbee; Paul E de Jong
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

3.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

4.  Microalbuminuria in the US population: third National Health and Nutrition Examination Survey.

Authors:  Camille A Jones; Mildred E Francis; Mark S Eberhardt; Blanche Chavers; Josef Coresh; Michael Engelgau; John W Kusek; Danita Byrd-Holt; K M Venkat Narayan; William H Herman; Camara P Jones; Marcel Salive; Lawrence Y Agodoa
Journal:  Am J Kidney Dis       Date:  2002-03       Impact factor: 8.860

5.  Ethnic disparities in diabetic complications in an insured population.

Authors:  Andrew J Karter; Assiamira Ferrara; Jennifer Y Liu; Howard H Moffet; Lynn M Ackerson; Joe V Selby
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

6.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

7.  Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study.

Authors:  Maureen A Murtaugh; David R Jacobs; Xinhua Yu; Myron D Gross; Michael Steffes
Journal:  Am J Epidemiol       Date:  2003-10-01       Impact factor: 4.897

8.  Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans.

Authors:  Bessie A Young; Charles Maynard; Edward J Boyko
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Authors:  Shay Tzur; Saharon Rosset; Revital Shemer; Guennady Yudkovsky; Sara Selig; Ayele Tarekegn; Endashaw Bekele; Neil Bradman; Walter G Wasser; Doron M Behar; Karl Skorecki
Journal:  Hum Genet       Date:  2010-07-16       Impact factor: 4.132
View more
  4 in total

Review 1.  Insights into the genetic architecture of diabetic nephropathy.

Authors:  Nicholette D Palmer; Barry I Freedman
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 2.  Effect of race and genetics on vitamin D metabolism, bone and vascular health.

Authors:  Barry I Freedman; Thomas C Register
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

Review 3.  Diabetes and its comorbidities--where East meets West.

Authors:  Alice P S Kong; Gang Xu; Nicola Brown; Wing-Yee So; Ronald C W Ma; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2013-05-28       Impact factor: 43.330

4.  Low-grade albuminuria is associated with hearing loss in non-diabetic US males: A cross-sectional analysis of 1999-2004 national health and nutrition examination survey.

Authors:  Tang-Chuan Wang; Ta-Yuan Chang; Richard Salvi; Chun-Jung Juan; Yi-Wen Liu; Chia-Hao Chang; Chien-Jen Chiu; Chia-Der Lin; Ming-Hsui Tsai
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.